During the past decade, Nzoz Medi-Spatz conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Nzoz Medi-Spatz" are "Osteoarthritis, Hip" (2 trials), "Knee Osteoarthritis" (1 trials), "Osteo Arthritis Shoulders" (1 trials), "Osteoarthritis Ankle" (1 trials) and "Osteoarthritis of the Knee" (1 trials). Many other conditions were trialed in "Nzoz Medi-Spatz" in a lesser frequency.

Most popular intervention types in "Nzoz Medi-Spatz" are "Device" (7 trials), "Combination Product" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cingal" (5 trials), "Monovisc" (4 trials) and "Triamcinolone Hexacetonide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nzoz Medi-Spatz" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Nzoz Medi-Spatz". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Nzoz Medi-Spatz, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Nzoz Medi-Spatz, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".